RECCE PHARMACEUTICALS Ltd (ASX:RCE) Pauses Trading Pending Further Announcement
RECCE PHARMACEUTICALS Ltd (ASX:RCE) has temporarily paused trading in its securities pending a further announcement.
The Hub of Australian Finance News
RECCE PHARMACEUTICALS Ltd (ASX:RCE) has temporarily paused trading in its securities pending a further announcement.
VHM Limited (ASX:VHM) announces a staged expansion of its Goschen Project, aiming for first production in two years with significant financial metrics.
Krakatoa Resources Ltd (ASX:KTA) advances its Zopkhito Antimony-Gold Project with significant resource estimates and plans for development by 2025.
Golden Cross Resources Ltd (ASX:GCR) has commenced gravity surveys at its Copper Hill project, enhancing exploration data and supporting resource development.
Althea Group Holdings (ASX:AGH) revises its FY25 revenue guidance to $26-$33 million and adjusts EBITDA expectations amidst strategic restructuring.
Australian Rare Earths (ASX:AR3) confirms uranium mineralisation in initial Overland Project drill holes, validating its geological model.
Bounty Oil & Gas NL (ASX:BUY) files for judicial review challenging permit refusal by the Commonwealth-New South Wales Offshore Petroleum Joint Authority.
Neurotech International Ltd (ASX:NTI) signs a development agreement with RH Pharma to develop cannabinoid therapies for pediatric neurological disorders.
Austal Limited (ASX:ASB) secures a A$275 million contract to design and build a hydrogen-ready passenger ferry for Gotlandsbolaget.
OzAurum Resources (ASX:OZM) reports a new high-grade gold discovery at Mulgabbie North, highlighting significant drill results and enhanced project potential.